Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thierry Trenque

Showing results (11-20 of 52) with videos related to

Pageof 6
Sort By:
Drug Safety|November 15, 2011
Serotonin reuptake inhibitors and hyperprolactinaemia: a case/non-case study in the French pharmacovigilance databaseThierry Trenque, Emmanuelle Herlem, Pascal Auriche, et al.
Expert Opinion on Drug Safety|August 4, 2018
Psoriasis during angiotensin receptor blocker exposure: an underestimated adverse drug reactionBrahim Azzouz, Malak Abou Taam, Aurore Morel, et al.
Springerplus|October 4, 2014
Methylphenidate off-label use and safetyThierry Trenque, Emmanuelle Herlem, Malak Abou Taam, et al.
Therapie|August 29, 2003
[Drug-induced hyperprolactinemia: a case-non-case study from the national pharmacovigilance database]Abir Petit, Dorothée Piednoir, Marie-Laure Germain, et al.
Therapie|March 14, 2007
[Hyponatremia induced by sodium valproate. A case report]Nathalie Herment, Emmanuelle Herlem, Marie-Laure Germain, et al.
Fundamental & Clinical Pharmacology|June 18, 2016
Bisphosphonate-related osteonecrosis of the jaw: data from the French national pharmacovigilance databasePaul de Boissieu, Louise Gaboriau, Aurore Morel, et al.
European Journal of Clinical Pharmacology|January 7, 2022
Immune-mediated necrotizing myopathy with pembrolizumab: a specific neuromuscular entityThierry Trenque, Elise Lepoix, Agathe Trenque, et al.
Therapie|June 5, 2021
[DRESS syndrome to phenobarbital: A hypersensitivity reaction to drugs known but forgotten by prescribers-A case report]Camille Douilly, Elise Lepoix, Brahim Azzouz, et al.
Drug Safety|October 11, 2019
Psoriasis After Exposure to Angiotensin-Converting Enzyme Inhibitors: French Pharmacovigilance Data and Review of the LiteratureBrahim Azzouz, Aurore Morel, Lukshe Kanagaratnam, et al.
Therapie|March 6, 2023
Osteonecrosis of the jaw with axitinib: A case reportSalomé Martin, Thierry Trenque, Angélique Bergeret, et al.
Pageof 6

Showing results (11-20 of 52) with videos related to

Sort By:
Pageof 6
Drug Safety|November 15, 2011
Serotonin reuptake inhibitors and hyperprolactinaemia: a case/non-case study in the French pharmacovigilance databaseThierry Trenque, Emmanuelle Herlem, Pascal Auriche, et al.
Expert Opinion on Drug Safety|August 4, 2018
Psoriasis during angiotensin receptor blocker exposure: an underestimated adverse drug reactionBrahim Azzouz, Malak Abou Taam, Aurore Morel, et al.
Springerplus|October 4, 2014
Methylphenidate off-label use and safetyThierry Trenque, Emmanuelle Herlem, Malak Abou Taam, et al.
Therapie|August 29, 2003
[Drug-induced hyperprolactinemia: a case-non-case study from the national pharmacovigilance database]Abir Petit, Dorothée Piednoir, Marie-Laure Germain, et al.
Therapie|March 14, 2007
[Hyponatremia induced by sodium valproate. A case report]Nathalie Herment, Emmanuelle Herlem, Marie-Laure Germain, et al.
Fundamental & Clinical Pharmacology|June 18, 2016
Bisphosphonate-related osteonecrosis of the jaw: data from the French national pharmacovigilance databasePaul de Boissieu, Louise Gaboriau, Aurore Morel, et al.
European Journal of Clinical Pharmacology|January 7, 2022
Immune-mediated necrotizing myopathy with pembrolizumab: a specific neuromuscular entityThierry Trenque, Elise Lepoix, Agathe Trenque, et al.
Therapie|June 5, 2021
[DRESS syndrome to phenobarbital: A hypersensitivity reaction to drugs known but forgotten by prescribers-A case report]Camille Douilly, Elise Lepoix, Brahim Azzouz, et al.
Drug Safety|October 11, 2019
Psoriasis After Exposure to Angiotensin-Converting Enzyme Inhibitors: French Pharmacovigilance Data and Review of the LiteratureBrahim Azzouz, Aurore Morel, Lukshe Kanagaratnam, et al.
Therapie|March 6, 2023
Osteonecrosis of the jaw with axitinib: A case reportSalomé Martin, Thierry Trenque, Angélique Bergeret, et al.
Pageof 6